ENOV
Enovis·NYSE
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 3
Bearish signal 2
Consensus Rating "Strong Buy"
Significant Net Income Decline
Revenue Beats Expectation
RSI Oversold
EPS Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About ENOV
Enovis Corporation
A global orthopedic company that develops and commercializes innovative biologic and synthetic products for musculoskeletal and sports medicine applications
Healthcare Equipment and Supplies
Invalid Date
05/08/2008
New York Stock Exchange
7,367
12-31
Common stock
2711 Centerville Road, Suite 400, Wilmington, Delaware 19808
--
Enovis Corporation was established in 1995. The company is an innovation-driven medical technology growth company that develops clinically differentiated solutions that generate better patient outcomes and transform workflows. Driven by the continuous improvement of global talent and innovation culture, the company's extensive products, services and comprehensive technologies all drive active lifestyles in orthopedics and other fields.
Earnings Call
Q2/2025
Estimate EPS0.72
Actual EPS0.79
Estimate Revenue554.62M
Actual Revenue564.54M
Enovis' Q2 2025: Unraveling Contradictions in Recon Growth, Market Dynamics, and Financial Strategy
Aug 08,2025 06:19
Earnings Decrypt
Earnings Decrypt
Q1/2025
Estimate EPS0.74
Actual EPS0.81
Estimate Revenue558.90M
Actual Revenue558.83M
Contradictions Unveiled: Enovis Corporation's 2025 Q1 Earnings Call on Tariffs, Market Growth, and Economic Resilience
May 19,2025 07:53
Earnings Decrypt
Earnings Decrypt
Company Financials
EPS
ENOV has released its 2025 Q3 earnings. EPS was reported at 0.75, versus the expected 0.65, beating expectations. The chart below visualizes how ENOV has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
ENOV has released its 2025 Q3 earnings report, with revenue of 548.91M, reflecting a YoY change of 8.65%, and net profit of -570.91M, showing a YoY change of -1726.22%. The Sankey diagram below clearly presents ENOV's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
